Corporate Profile KalVista is a pharmaceutical company focused on the discovery, development and commercialization of small molecule protease inhibitors as new treatments for diseases with significant unmet needs. Minimum 15 minutes delayed. Source: LSEG View All Stock Information All Stock Information
KalVista Pharmaceuticals Presents New Data Highlighting the Burden of Injectable On-Demand Treatment in Young Children with Hereditary Angioedema May 28, 2026
Chiesi Group to Acquire KalVista Pharmaceuticals, Expanding its Global Rare Disease Portfolio Apr 29, 2026
KalVista Pharmaceuticals to Present at the 25th Annual Needham Virtual Healthcare Conference Apr 08, 2026
